Mark Layton
Impact in
- Physiology top 1%
- Adenosine and Purinergic Signaling
- Genetics top 2%
- Hemoglobinopathies and Related Disorders
Papers in
- Genetics 26
- Hemoglobinopathies and Related Disorders 26
- Genomics and Rare Diseases 4
- Hematology 19
- Acute Myeloid Leukemia Research 5
- Co-authors
- Sally Hollis (2 shared papers)Iain B. McInnes (1 shared paper)Edward Clark Keystone (1 shared paper)J. W. G. Janssen (2 shared papers)Ghulam Mufti (2 shared papers)B. Modell (5 shared papers)David R. Roper (5 shared papers)Michael Buschle (2 shared papers)
- Journals
- Blood (9 papers)British Journal of Haematology (9 papers)The Lancet Rheumatology (3 papers)The Lancet (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Layton
75 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 98
- Physiology 196
- Genetics 430
- Hematology 661
- Pediatrics, Perinatology and Child Health 156
- Rheumatology 161
Countries citing papers authored by Mark Layton
This map shows the geographic impact of Mark Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Layton more than expected).
Fields of papers citing papers by Mark Layton
This network shows the impact of papers produced by Mark Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Layton. The network helps show where Mark Layton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 292 | |
| 2 | 1989 | 262 | |
| 3 | 1988 | 106 | |
| 4 | 2020 | 92 | |
| 5 | 2004 | 90 | |
| 6 | 1999 | 80 | |
| 7 | 1995 | 76 | |
| 8 | 1997 | 72 | |
| 9 | 2018 | 72 | |
| 10 | 2013 | 63 | |
| 11 | 2010 | 58 | |
| 12 | A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. | 2001 | 57 |
| 13 | 2018 | 56 | |
| 14 | 2016 | 51 | |
| 15 | 2000 | 42 | |
| 16 | 2022 | 40 | |
| 17 | 1998 | 39 | |
| 18 | 2006 | 39 | |
| 19 | 1990 | 37 | |
| 20 | 2009 | 35 |
About Mark Layton
Mark Layton is a scholar working on Genetics, Hematology, Pediatrics, Perinatology and Child Health, Rheumatology and Physiology, having authored 77 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (26 papers), Acute Myeloid Leukemia Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Genomics and Rare Diseases (4 papers), Neonatal Health and Biochemistry (4 papers), Metabolism and Genetic Disorders (4 papers), Erythrocyte Function and Pathophysiology (4 papers) and Clinical Laboratory Practices and Quality Control (3 papers). The work is most often cited by research in Physiology (196 citations), Genetics (430 citations), Hematology (661 citations), Pediatrics, Perinatology and Child Health (156 citations) and Rheumatology (161 citations). Mark Layton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sally Hollis, Iain B. McInnes, Edward Clark Keystone, J. W. G. Janssen, Ghulam Mufti, B. Modell, David R. Roper, Michael Buschle, H. Heimpel and Herman VAN DEN BERGHE. Their work appears in journals such as Blood, British Journal of Haematology, The Lancet Rheumatology, The Lancet and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.